A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
基本信息
- 批准号:8617090
- 负责人:
- 金额:$ 72.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-07 至 2016-02-29
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdrenergic AgonistsAfferent NeuronsAftercareAnatomic SitesAutomobile DrivingBehavioralBrain StemCalcium ChannelCalcium SignalingCervical spinal cord structureChronicClinicalComplexConfocal MicroscopyCytophotometryDataDevelopmentElectron MicroscopyGangliaGoalsHypersensitivityInjuryKnockout MiceLigandsMeasurementMediatingMediator of activation proteinModelingMusNerveNeuronsNociceptionOrofacial PainPainPathway interactionsPatientsPeripheralPeripheral nerve injuryPharmaceutical PreparationsPhysiologicalPlayPosterior Horn CellsProcessProtein SubunitsRattusRegulationRoleSamplingSensorySerotonin Receptors 5-HT-3SiteSliceSpinalSpinal CordSpinal nerve structureStructure of trigeminal ganglionSynapsesSynaptic TransmissionSyndromeTactileTertiary Protein StructureTestingTherapeutic AgentsTimeTrigeminal SystemTrigeminal nerve structureViralViral Vectorallodyniabasechannel blockerschronic constriction injurychronic paincraniofacialdigitalgabapentininterdisciplinary approachnerve injuryneuronal excitabilitynovelorofacialoverexpressionpainful neuropathypreventprogramspublic health relevancereceptorresearch studysynaptogenesisthrombospondin 4voltage
项目摘要
DESCRIPTION (provided by applicant): Chronic orofacial pain is a common clinical syndrome lacking specific and effective therapeutic agents due to the fact that cellular mechanisms of chronic orofacial pain are poorly understood. Based on our preliminary data from a trigeminal nerve injury model and in non-orofacial pain models, we hypothesize that trigeminal nerve injury induced thrombospondin-4 (TSP4) expression in trigeminal ganglia (TG) and associated brainstem/upper cervical spinal cord (Vc/C2) that causes sensory neuron hyperexcitability, and abnormal synaptogenesis in the trigeminal complex in the spinal cord. These changes underlie the transition from trigeminal nerve injury to chronic pain development. In this proposal, we plan to identify the critical domain(s) of TSP4 in mediating behavioral hypersensitivity and spinal neuron hyperexcitability. Viral driven TSP4 expression in TG or Vc/C2, respectively, will be used to identify the site of the TSP4's action in chronic pain processing. We will perform confocal and electron microscopy to determine the extent of abnormal synaptogenesis in the nerve injury models. In addition, the influence of descending modulatory pathways and voltage-gated-calcium channels on TSP4-mediated behavioral hypersensitivity and dorsal horn neuron hyperexcitability will be studies using respective drugs. The influence of TSP4 on sensory neuron excitability, calcium channel activities, and intracellular calcium signaling will be studied in isolated neurons or intact TG from nerve injury models, or after TSP4 treatment. To determine if TSP4 induces behavioral hypersensitivity and dorsal horn neuron hyperexcitability through its interactions with its receptor, the calcium channel alpha-2-delta-1 subunit (Cava2d1), in a sensory neuron specific manner, Cava2d1 conditional knockout mice with selective deletion of Cava2d1 in subpopulation of sensory neurons will be used for these studies. The final goal of the proposed studies is to identify the peripheral and/or central mechanisms underlying TSP4-mediated transition to chronic pain states after trigeminal nerve injury.
描述(由申请人提供):慢性口面疼痛是一种常见的临床综合征,缺乏特定且有效的治疗剂,因为人们对慢性口面部疼痛的细胞机制知之甚少。根据我们的初步数据,来自三叉神经损伤模型和非口交疼痛模型,我们假设三叉神经损伤诱导的三叉神经节神经节(TG)和相关的脑干/上宫颈脊髓(VC/C2)的脑干神经节(VC/C2)的构型造成感觉神经性神经性神经均匀性和均匀性和均匀性的均匀性和均匀性,并导致了造成的脑干神经节(TSP4)的表达脊髓中的复合物。这些变化是从三叉神经损伤到慢性疼痛发展的过渡。在此提案中,我们计划在介导行为超敏反应和脊髓神经元过敏性中识别TSP4的关键域。 TG或VC/C2中的病毒驱动TSP4表达将用于识别TSP4在慢性疼痛处理中作用的位点。我们将执行共聚焦和电子显微镜,以确定神经损伤模型中突触异常的程度。此外,下降调节途径和电压门控钙通道对TSP4介导的行为超敏反应和背角神经元过敏性的影响将是使用各自的药物进行研究。 TSP4对孤立的神经元或神经损伤模型的完整TG或TSP4处理后,将研究TSP4对感觉神经元兴奋性,钙通道活性和细胞内钙信号的影响。 To determine if TSP4 induces behavioral hypersensitivity and dorsal horn neuron hyperexcitability through its interactions with its receptor, the calcium channel alpha-2-delta-1 subunit (Cava2d1), in a sensory neuron specific manner, Cava2d1 conditional knockout mice with selective deletion of Cava2d1 in subpopulation of sensory neurons will be used for these studies.拟议的研究的最终目标是确定TSP4介导的三叉神经损伤后TSP4介导的向慢性疼痛状态过渡的外围和/或中心机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZHIGANG David LUO其他文献
ZHIGANG David LUO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZHIGANG David LUO', 18)}}的其他基金
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
验证阻断 TSP4/Cava2d1 相互作用作为神经性疼痛的新靶点
- 批准号:
10552492 - 财政年份:2022
- 资助金额:
$ 72.28万 - 项目类别:
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
验证阻断 TSP4/Cava2d1 相互作用作为神经性疼痛的新靶点
- 批准号:
10452913 - 财政年份:2021
- 资助金额:
$ 72.28万 - 项目类别:
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
验证阻断 TSP4/Cava2d1 相互作用作为神经性疼痛的新靶点
- 批准号:
10670457 - 财政年份:2019
- 资助金额:
$ 72.28万 - 项目类别:
Nanoparticle mediated in vivo cell-type specific drug delivery for pain relief
纳米颗粒介导体内细胞类型特异性药物递送以缓解疼痛
- 批准号:
8364809 - 财政年份:2012
- 资助金额:
$ 72.28万 - 项目类别:
Nanoparticle mediated in vivo cell-type specific drug delivery for pain relief
纳米颗粒介导体内细胞类型特异性药物递送以缓解疼痛
- 批准号:
8501694 - 财政年份:2012
- 资助金额:
$ 72.28万 - 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
- 批准号:
8101208 - 财政年份:2011
- 资助金额:
$ 72.28万 - 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
- 批准号:
8254372 - 财政年份:2011
- 资助金额:
$ 72.28万 - 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
- 批准号:
8420544 - 财政年份:2011
- 资助金额:
$ 72.28万 - 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
- 批准号:
8705625 - 财政年份:2011
- 资助金额:
$ 72.28万 - 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面神经病理性疼痛发展的新途径
- 批准号:
8804851 - 财政年份:2011
- 资助金额:
$ 72.28万 - 项目类别:
相似国自然基金
肾上腺素能受体激动剂引起睑板腺功能障碍发病的机制研究
- 批准号:82371024
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
水体中β2-肾上腺素受体激动剂(PPCPs)间接光降解机理的量子化学与实验研究
- 批准号:22306084
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α2A/2B-肾上腺素受体偏向激活Gαs的激动剂作用位点及其功能相关性研究
- 批准号:82273909
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
α2A/2B-肾上腺素受体偏向激活Gαs的激动剂作用位点及其功能相关性研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
β3肾上腺素受体激动剂对小鼠肩袖延迟修复后肌肉脂肪浸润的治疗作用及机制研究
- 批准号:81902245
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms of Sympathetic Overactivity in Post-traumatic Stress Disorder
创伤后应激障碍中交感神经过度活跃的机制
- 批准号:
9891297 - 财政年份:2015
- 资助金额:
$ 72.28万 - 项目类别:
Mechanisms of Sympathetic Overactivity in Post-traumatic Stress Disorder
创伤后应激障碍中交感神经过度活跃的机制
- 批准号:
10409640 - 财政年份:2015
- 资助金额:
$ 72.28万 - 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
- 批准号:
8101208 - 财政年份:2011
- 资助金额:
$ 72.28万 - 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
- 批准号:
8254372 - 财政年份:2011
- 资助金额:
$ 72.28万 - 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
- 批准号:
8420544 - 财政年份:2011
- 资助金额:
$ 72.28万 - 项目类别: